title: Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.
authors.forename: German
authors.initials: G
authors.lastname: Reyes-Botero
authors.forename: Jaime
authors.initials: J
authors.lastname: Gállego Pérez-Larraya
authors.forename: Jaime
authors.initials: J
authors.lastname: Gallego Pérez-Larraya
authors.forename: Marc
authors.initials: M
authors.lastname: Sanson
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001921:Brain / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D018325:Hemangioblastoma / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D011086:Polycythemia / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects*; D013116:Spinal Cord / Q000473:pathology; D000077210:Sunitinib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib
references.citation: Arch Pathol Lab Med. 2008 Jan;132(1):104-8
references.pmid: 18181660
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: Open Ophthalmol J. 2010 Oct 21;4:66-9
references.pmid: 21293730
references.citation: J Neuroimaging. 1997 Oct;7(4):242-4
references.pmid: 9344008
references.citation: Blood. 2002 May 15;99(10):3851-3
references.pmid: 11986247
references.citation: J Neurooncol. 2011 Jan;101(2):307-10
references.pmid: 20524042
references.citation: J Neurosurg. 2002 Apr;96(4):775-87
references.pmid: 11990821